Adult Acute Myeloid Leukemia With T(8;21)(q22;q22) Terminated Phase 1 Trials for Cytarabine (DB00987)

Also known as: Adult Acute Myeloid Leukemia With t(8;21)(q22;q22)

IndicationStatusPhase
DBCOND0036073 (Adult Acute Myeloid Leukemia With T(8;21)(q22;q22))Terminated1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01849276Metformin+Cytarabine for the Treatment of Relapsed/Refractory AMLTreatment
NCT01904643Lenalidomide and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Myeloid LeukemiaTreatment
NCT02049801MEK Inhibitor MEK162, Idarubicin, and Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid LeukemiaTreatment